Review of fecal biomarkers in inflammatory bowel disease
- PMID: 18543035
- DOI: 10.1007/s10350-008-9310-8
Review of fecal biomarkers in inflammatory bowel disease
Abstract
Purpose: We reviewed potential fecal biomarkers of inflammatory bowel disease and assessed their utility in a range of clinical applications.
Methods: A literature search using PubMed, MEDLINE, and Embase database was performed, locating all language articles on fecal biomarkers, including calprotectin and lactoferrin. The references of these papers were searched manually for further references.
Results: A wide range of fecal biomarkers have been evaluated in the research setting. Only fecal calprotectin and lactoferrin have translated into useful clinical tools. These biomarkers have demonstrated high sensitivity for organic intestinal disease and good correlation with other measures of disease activity in inflammatory bowel disease.
Conclusions: Fecal calprotectin and lactoferrin are useful triage tools to differentiate organic intestinal disorders from functional disorders. They also have a role in monitoring inflammatory bowel disease activity and predicting relapse.
Similar articles
-
Technology insight: calprotectin, lactoferrin and nitric oxide as novel markers of inflammatory bowel disease.Nat Clin Pract Gastroenterol Hepatol. 2005 Feb;2(2):96-102. doi: 10.1038/ncpgasthep0094. Nat Clin Pract Gastroenterol Hepatol. 2005. PMID: 16265127 Review.
-
Fecal markers: calprotectin and lactoferrin.Gastroenterol Clin North Am. 2012 Jun;41(2):483-95. doi: 10.1016/j.gtc.2012.01.007. Epub 2012 Feb 16. Gastroenterol Clin North Am. 2012. PMID: 22500530 Review.
-
Clinical utility of calprotectin and lactoferrin as markers of inflammation in patients with inflammatory bowel disease.Expert Rev Clin Immunol. 2010 Jul;6(4):551-8. doi: 10.1586/eci.10.26. Expert Rev Clin Immunol. 2010. PMID: 20594128
-
Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.Am J Gastroenterol. 2008 Jan;103(1):162-9. doi: 10.1111/j.1572-0241.2007.01556.x. Epub 2007 Oct 4. Am J Gastroenterol. 2008. PMID: 17916108
-
Fecal lactoferrin and calprotectin after ileocolonic resection for Crohn's disease.Dis Colon Rectum. 2007 Jun;50(6):861-9. doi: 10.1007/s10350-007-0225-6. Dis Colon Rectum. 2007. PMID: 17473939
Cited by
-
Inter-alpha inhibitor protein level in neonates predicts necrotizing enterocolitis.J Pediatr. 2010 Nov;157(5):757-61. doi: 10.1016/j.jpeds.2010.04.075. Epub 2010 Jun 17. J Pediatr. 2010. PMID: 20955849 Free PMC article.
-
Fecal lactoferrin in discriminating inflammatory bowel disease from irritable bowel syndrome: a diagnostic meta-analysis.BMC Gastroenterol. 2014 Jul 7;14:121. doi: 10.1186/1471-230X-14-121. BMC Gastroenterol. 2014. PMID: 25002150 Free PMC article. Review.
-
Clinical Significance of Inflammatory Biomarkers in Acute Pediatric Diarrhea.Pediatr Gastroenterol Hepatol Nutr. 2019 Jul;22(4):369-376. doi: 10.5223/pghn.2019.22.4.369. Epub 2019 Jun 18. Pediatr Gastroenterol Hepatol Nutr. 2019. PMID: 31338312 Free PMC article.
-
Protein biomarkers in exfoliated cells collected from the human rectal mucosa: implications for colorectal disease detection and monitoring.Int J Colorectal Dis. 2011 Oct;26(10):1287-97. doi: 10.1007/s00384-011-1263-z. Epub 2011 Jun 23. Int J Colorectal Dis. 2011. PMID: 21698353
-
A Longitudinal Study of Household Water, Sanitation, and Hygiene Characteristics and Environmental Enteropathy Markers in Children Less than 24 Months in Iquitos, Peru.Am J Trop Med Hyg. 2018 Apr;98(4):995-1004. doi: 10.4269/ajtmh.17-0464. Epub 2018 Feb 8. Am J Trop Med Hyg. 2018. PMID: 29436350 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical